{"disease":{"id":"leber-hereditary-optic-neuropathy-lhon","name":"leber hereditary optic neuropathy lhon"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04912843","title":"Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Wuhan Neurophth Biotechnology Limited Company","has_results":false},{"nct_id":"NCT07406854","title":"A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":95,"lead_sponsor_name":"Wuhan Neurophth Biotechnology Limited Company","has_results":false},{"nct_id":"NCT05555784","title":"Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Argo Sante","has_results":false},{"nct_id":"NCT05820152","title":"Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Neurophth Therapeutics Inc","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}